Politico Pro: House passes PBM transparency bills

POLITICO PRO, SARAH KARLIN-SMITH

The House today unanimously passed a bill that would require more public disclosure of the discounts drug companies give to pharmacy benefit managers.

Rep. Abigail Spanberger’s bill, H.R. 2115 (116), approved 403-0, would require PBMs to report to HHS their aggregate rebates, discounts and other price concessions received on drugs from manufacturers. The department would then be required to publicly post aggregate rebate data and generic dispensing rates online. Information on rebates would be posted on the drug class level, as long as there are at least three drugs in the class and the information does not display confidential information for rebates received for an individual drug.

The bill would also make public some information available on the compensation PBMs receive from pharmacies.

The House later passed by voice vote a measure by Rep. Buddy Carter, H.R. 1781 (116), which would give MedPac and MACPAC access to drug pricing and rebate data to help Congress better understand how the drug market is operating.

The goal of both bills is to obtain more data to try and address concerns that PBMs may be contributing to higher drug prices by favoring high-list price drugs with large rebates. PBMs are accused of pocketing the sum of these rebates as profits and then basing patients share of a drug off the list price. The PBMs argue they use rebates to lower the cost of patients premiums.

Spanberger’s bill would additionally require Medicare Part D plans to provide patients with information that is integrated into their health care providers’ electronic prescribing system or electronic health records about their cost-sharing responsibility for a drug as well as their cost-sharing for clinically appropriate alternatives on their plan’s formulary. Plans will have to provide these out-of-pocket costs for the drugs at a variety of nearby pharmacies, so patients can determine the be option.

Recent Posts


Feb 23, 2024
Local Issues

Spanberger, Garbarino Lead Bipartisan Bill to Track & Report Tick Bite-Associated Condition, Alpha-Gal Syndrome

The Congresswoman’s “Recognize AGS Act” Would Direct HHS to Make Alpha-Gal Syndrome a Nationally Notifiable Disease WASHINGTON, D.C. — U.S. Representatives Abigail Spanberger (D-VA-07) and Andrew R. Garbarino (R-NY-02) introduced bipartisan legislation to allow for greater monitoring and reporting of alpha-gal syndrome (AGS) cases by the Centers for Disease Control and Prevention (CDC). Alpha-gal syndrome […]



Feb 22, 2024
Press

Spanberger Urges Health Insurers to Fully Cover Birth Control, As Required by the Affordable Care Act

This Effort Comes After Years of Systemic Noncompliance by Insurance Plans & Women Paying Out of Pocket or Facing Administrative Red Tape to Access Birth Control WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today joined more than 150 U.S. House and U.S. Senate colleagues in urging health insurers to improve access to birth control by […]



Feb 21, 2024
Press

Spanberger Announces Sixth Annual Congressional Art Competition, Invites Virginia High School Students to Submit Artwork

The Winner’s Artwork Will Be Displayed in the U.S. Capitol Building for One Year Alongside Winners from All 50 States WOODBRIDGE, Va. — U.S. Representative Abigail Spanberger today invited high school students from Virginia’s Seventh District to submit original artwork for the annual Congressional Art Competition. Every year, Members of the U.S. House of Representatives […]